Skip to content

Cognitive Training Using VR Contents

Cognitive Training for overweight and obese adults Using VR Contents

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007014
Enrollment
60
Registered
2022-02-18
Start date
2022-02-14
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The selected subjects are randomly assigned to a test group or a control group, and divided into A) a VR training group that actually runs a VR-based cognitive function training progr

Sponsors

The Catholic University of Korea
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Overweight to obesity: between 23 and 34.9 kg/m2 on the Body Mass Index - Adult men and women between the ages of 19 and 75 - Those with a score of 24 or higher based on the Korean Version of Mini Mental Status Examination (MMSE-KC) - Those who voluntarily consent to the study and are able to visit for the next observation

Exclusion criteria

Exclusion criteria: - Hearing impairment accompanied by severe visual loss - Patients with severe movement disorders - Women who are pregnant - If a new history of severe wasting diseases such as thyroid disease, liver disease, or kidney disease is diagnosed within 3 months of the test - Severe infection, metabolic acidosis, acromegaly, Cushing's syndrome - Patients with psychiatric disorders that can seriously affect the nervous system or take drugs - In case of intracranial surgery history and magnetic material inserted into the head or eyeball - When implants such as artificial pacemakers, hearing aids, or drug infusion pumps - Have a history or symptom of epilepsy or seizure disorder - A clinically significant disease in renal (glomerulonephritis, renal failure), cardiac (angina pectoris, myocardial infarction, heart failure), respiratory (respiratory failure syndrome), or nervous system (stroke, encephalitis, and meningitis) - Patients who do not understand or do not agree with the contents of the study - Patients judged to be inappropriate by other researchers

Design outcomes

Primary

MeasureTime frame
Changes in CERAD-K after 4 weeks from baseline

Secondary

MeasureTime frame
Structural/functional (parenchymal volume, gray matter thickness, functional connectivity) changes in brain imaging;Changes in psychological state (anxiety, depression scale);Changes in heart rate variability;Changes in Cognitive function test result in VR device

Countries

Korea, Republic of

Contacts

Public ContactYoungmi Eun

The Catholic University of Korea

wind2926@naver.com@wind2926@naver.com+82-2-3779-1024

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026